Literature DB >> 20236506

Functional relevance of IL-10 promoter polymorphisms for sepsis development.

Spaska A Stanilova.   

Abstract

The induced production of proinflammatory and anti-inflammatory cytokines is considered important for the development of sepsis and its sequelae. Polymorphisms in the IL-10 gene promoter could influence its expression and sepsis susceptibility. Results obtained by Dr Ling and colleagues demonstrated that the -1082A allele was significantly associated with lower lipopolysaccharide-induced IL-10 production in an allele-dose-dependent fashion. They also showed that this polymorphism was significantly associated with sepsis development after major trauma. These and other research data clearly demonstrated that the -1082 A/G polymorphism in the IL-10 gene promoter has an important impact on susceptibility of sepsis and sepsis outcome.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20236506      PMCID: PMC2875510          DOI: 10.1186/cc8839

Source DB:  PubMed          Journal:  Crit Care        ISSN: 1364-8535            Impact factor:   9.097


Dr Ling and colleagues performed a large prospective study, including 308 patients with major trauma, and determined that the genotype distribution of the IL-10 polymorphisms was associated with the sepsis morbidity rate and multiple organ dysfunction syndrome (MODS) scores [1]. The authors also investigated the association of polymorphisms with lipopolysaccharide-induced IL-10 production. Cytokine production varies between individuals, due to genetic background and certain allelic variants of cytokine genes - in particular, SNPs are associated with higher or lower cytokine production. The IL-10 5'-flanking region, which controls transcription, is polymorphic, with two microsatellites and three SNPs (-1082, -819, and -592) [2]. Polymorphisms in the regulatory region of the IL-10 gene may influence its expression, and hence could influence the susceptibility of sepsis [3]. The authors investigated the hypothesis that SNPs located in the cis-regulatory region of IL-10 promoter might represent a risk factor or a protective factor for developing sepsis and might influence the MODS score after major trauma. The results obtained by Dr Ling and colleagues demonstrated that both the -1082A and -592A alleles were significantly associated with lower lipopolysaccharide-induced IL-10 production in an allele-dose-dependent fashion. In contrast, there was no significant difference for association between the -819 polymorphism and induced cytokine production. These results are in agreement with the data from Turner and colleagues, who found that the IL-10 -1082A allele is associated with lower in vitro IL-10 production by concanavalin-A-stimulated peripheral blood mono nuclear cells from normal subjects [2]. Moreover, Stanilova and colleagues reported that carriage of at least one copy of the IL-10 -1082A allele in sepsis patients as well as in healthy controls resulted in a statistically significant decrease of IL-10 production from stimulated peripheral blood mononuclear cells, regardless of the stimuli used [4]. Altered host defense mechanisms are considered important for the development of sepsis and septic shock. Proinflammatory and anti-inflammatory responses contribute to the development and outcome of severe sepsis [5]. Cytokines play a pivotal role in the regulation of the type and magnitude of the immune response, and the polymorphic nature of the cytokine genes may confer flexibility on the immune response. The gene encoding IL-10 cytokine involved in the modulation of inflammatory responses as a main anti-inflammatory agent is therefore a candidate gene for determination of the human genetic background, which is responsible for interindividual differences in susceptibility to sepsis development. Previous reports have indicated that increased IL-10 production might be associated with the susceptibility and outcome of the sepsis [6-8]. The polymorphism at position -1082 in the promoter region of the IL-10 gene has been studied by Shu and colleagues, who reported an association of this polymorphism with susceptibility to severe sepsis - in contrast to the other two linked IL-10 polymorphisms (-592 and -819) in the same gene region [9]. Stanilova and colleagues showed that the A allele of the -1082 polymorphism in the IL-10 gene promoter is associated with sepsis susceptibility, whereas the G allele is associated with higher stimulated IL-10 production and increased mortality in severe sepsis [4]. Ling and colleagues also showed that, unlike the -1082 polymorphism, the -819 and -592 polymorphisms were not significantly associated with the sepsis morbidity rate and MODS scores. These collective data clearly demonstrated that the -1082 A/G polymorphism in the IL-10 gene has an important impact on susceptibility of sepsis and sepsis outcome. This effect is due to the anti-inflammatory and immunoregulatory properties of IL-10. The excess of IL-10 production in trauma patients or other critically ill patients determined by the -1082G allele could be responsible for inducing immuno-suppression and subsequently developing bacterial sepsis and MODS. The concentration of IL-10 in the blood - in most respects, lipopolysaccharide-induced IL-10 - is indicative for the magnitude of the inflammatory stress during sepsis and has been shown to correlate with both the severity and outcome of sepsis. Whether cytokine determination and genotyping in critically ill patients could optimize treatment and sepsis outcome should be determined by further randomized studies.

Abbreviations

IL: interleukin; MODS: multiple organ dysfunction syndrome; SNP: single nucleotide polymorphism.

Competing interests

The author declares that they have no competing interests.
  9 in total

1.  Interleukin-10-1082 promoter polymorphism in association with cytokine production and sepsis susceptibility.

Authors:  Spaska A Stanilova; Lyuba D Miteva; Zhivko T Karakolev; Chavdar S Stefanov
Journal:  Intensive Care Med       Date:  2006-01-25       Impact factor: 17.440

2.  High interleukin 12 and low interleukin 10 production after in vitro stimulation detected in sepsis survivors.

Authors:  Spaska A Stanilova; Zhivko T Karakolev; Gospodin S Dimov; Zlatka G Dobreva; Lyuba D Miteva; Emil S Slavov; Chavdar S Stefanov; Noyko S Stanilov
Journal:  Intensive Care Med       Date:  2005-02-18       Impact factor: 17.440

3.  An investigation of polymorphism in the interleukin-10 gene promoter.

Authors:  D M Turner; D M Williams; D Sankaran; M Lazarus; P J Sinnott; I V Hutchinson
Journal:  Eur J Immunogenet       Date:  1997-02

Review 4.  Effects of genomic polymorphisms on the course of sepsis: is there a concept for gene therapy?

Authors:  F Stüber
Journal:  J Am Soc Nephrol       Date:  2001-02       Impact factor: 10.121

5.  Pro- versus anti-inflammatory cytokine profile in patients with severe sepsis: a marker for prognosis and future therapeutic options.

Authors:  C A Gogos; E Drosou; H P Bassaris; A Skoutelis
Journal:  J Infect Dis       Date:  2000-01       Impact factor: 5.226

6.  Interleukin-10 controls the onset of irreversible septic shock.

Authors:  Samir Q Latifi; Mary Ann O'Riordan; Alan D Levine
Journal:  Infect Immun       Date:  2002-08       Impact factor: 3.441

7.  IL-10 polymorphism is associated with increased incidence of severe sepsis.

Authors:  Qiang Shu; Xiangming Fang; Qixing Chen; Frank Stuber
Journal:  Chin Med J (Engl)       Date:  2003-11       Impact factor: 2.628

8.  Clinical relevance of the interleukin 10 promoter polymorphisms in Chinese Han patients with major trauma: genetic association studies.

Authors:  Ling Zeng; Wei Gu; Kehong Chen; Dongpo Jiang; Lianyang Zhang; Dingyuan Du; Ping Hu; Qing Liu; Suna Huang; Jianxin Jiang
Journal:  Crit Care       Date:  2009-11-26       Impact factor: 9.097

9.  Cytokine profiles as markers of disease severity in sepsis: a multiplex analysis.

Authors:  Fernando A Bozza; Jorge I Salluh; André M Japiassu; Marcio Soares; Edson F Assis; Rachel N Gomes; Marcelo T Bozza; Hugo C Castro-Faria-Neto; Patrícia T Bozza
Journal:  Crit Care       Date:  2007       Impact factor: 9.097

  9 in total
  7 in total

Review 1.  Role of interleukin 10 transcriptional regulation in inflammation and autoimmune disease.

Authors:  Shankar Subramanian Iyer; Gehong Cheng
Journal:  Crit Rev Immunol       Date:  2012       Impact factor: 2.214

2.  Association between gene polymorphisms of IRAK-M and the susceptibility of sepsis.

Authors:  Gao-Hong Dong; Jian-Ping Gong; Jin-Zheng Li; Yu-Hong Luo; Zhen-Dong Li; Pei-Zhi Li; Kun He
Journal:  Inflammation       Date:  2013-10       Impact factor: 4.092

3.  Impaired TLR5 functionality is associated with survival in melioidosis.

Authors:  T Eoin West; Narisara Chantratita; Wirongrong Chierakul; Direk Limmathurotsakul; Vanaporn Wuthiekanun; Nicolle D Myers; Mary J Emond; Mark M Wurfel; Thomas R Hawn; Sharon J Peacock; Shawn J Skerrett
Journal:  J Immunol       Date:  2013-02-27       Impact factor: 5.422

4.  The association of polymorphisms of TLR4 and CD14 genes with susceptibility to sepsis in a Chinese population.

Authors:  Haiyan Wang; Yesheng Wei; Yi Zeng; Yueqiu Qin; Bin Xiong; Gang Qin; Jun Li; Donghai Hu; Xiaowen Qiu; Suren R Sooranna; Liao Pinhu
Journal:  BMC Med Genet       Date:  2014-11-14       Impact factor: 2.103

5.  Clinical relevance of single nucleotide polymorphisms within the 13 cytokine genes in North Indian trauma hemorrhagic shock patients.

Authors:  Dablu Lal Gupta; Predeep Kumar Nagar; Vineet Kumar Kamal; Sanjeev Bhoi; D N Rao
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2015-11-11       Impact factor: 2.953

6.  Interleukin 10 (IL10) and transforming growth factor β1 (TGFβ1) gene polymorphisms in persistent IgE-mediated cow's milk allergy.

Authors:  Cristina Miuki Abe Jacob; Antonio Carlos Pastorino; Thelma Suely Okay; Ana Paula B M Castro; Andrea Keiko F Gushken; Letícia Aki Watanabe; Vanessa C Z Frucchi; Léa Campos de Oliveira
Journal:  Clinics (Sao Paulo)       Date:  2013-07       Impact factor: 2.365

Review 7.  The Relevance of Coding Gene Polymorphysms of Cytokines and Cellular Receptors in Sepsis.

Authors:  Anca Meda Georgescu; Bianca Liana Grigorescu; Ioana Raluca Chirteș; Alexander A Vitin; Raluca Ștefania Fodor
Journal:  J Crit Care Med (Targu Mures)       Date:  2017-02-18
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.